Publicaciones en colaboración con investigadores/as de University of Florence (16)

2024

  1. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆

    Annals of Oncology, Vol. 35, Núm. 2, pp. 159-182

2022

  1. Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology

    Human reproduction (Oxford, England), Vol. 37, Núm. 11, pp. 2497-2502

2019

  1. The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

    Osteoporosis International, Vol. 30, Núm. 1, pp. 71-78

2018

  1. A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility

    PLoS ONE, Vol. 13, Núm. 12

  2. Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations

    PLoS ONE, Vol. 13, Núm. 1

  3. Timing of onset affects arthritis presentation pattern in antisynthetase syndrome

    Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 44-49

2017

  1. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

    American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

  2. Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study

    European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S85-S91

2016

  1. Padova Charter on personal injury and damage under civil-tort law: Medico-legal guidelines on methods of ascertainment and criteria of evaluation

    International Journal of Legal Medicine, Vol. 130, Núm. 1, pp. 1-12

  2. A novel methodology for the objective ascertainment of psychic and existential damage

    International Journal of Legal Medicine, Vol. 130, Núm. 5, pp. 1387-1399

  3. Off-label use of rituximab for systemic lupus erythematosus in Europe

    Lupus Science and Medicine, Vol. 3, Núm. 1

  4. Whiplash-Associated Disorders: Clinical and medico-legal guidelines on the methods of ascertainment

    International Journal of Legal Medicine, Vol. 130, Núm. 1, pp. 13-22

2013

  1. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis

    Human Molecular Genetics, Vol. 22, Núm. 11, pp. 2169-2176

2012

  1. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe

    European Journal of Cancer, Vol. 48, Núm. 8, pp. 1167-1175

2011

  1. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

    Nature Genetics

2008

  1. Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis

    Osteoporosis International, Vol. 19, Núm. 1, pp. 87-94